A comprehensive view of new use. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Army’s testbed ISR business jets are opening doors to new mission possibilities
Published: September 06, 2022 by Breaking Defense
Moderna completes submission to the FDA requesting emergency use authorization for Omicron-targeting bivalent COVID-19 booster vaccine; application is for a booster dose in adults age 18 years and older
Published: August 26, 2022 by Moderna Inc.
FBSciences announces EPA approval of its FBS Defense 500 for fungicide and insecticide uses, in addition to previous approvals; product helps combat biological resistance by controlling nematodes, insects, and fungal diseases in one ingredient
Published: June 08, 2022 by PR Newswire
Abbott announces approval in Japan to expand reimbursement coverage for its FreeStyle Libre system to include all people with diabetes who use insulin at least once a day; device is a continuous glucose monitoring system
Published: March 24, 2022 by Abbott Laboratories
Novavax announces emergency use authorization for Novavax protein-based COVID-19 vaccine for adolescents aged 12 to 18 in India; vaccine is manufactured and marketed in India by Serum Institute of India under the brand Covovax
Published: March 23, 2022 by Novavax Inc.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count